Patent · US Active

Pharmaceutical compositions of ranolazine

US8901128B2 · kind B2 · utility

3Cited by

5References

6Claims

0Family size

Assignee

LUPIN LIMITED · IN

Inventors

Ketan Bhasale · Pune, IN
Raghavendra Naik · Jamkhed, IN
Subhasis Das · Jamkhed, IN
Vijaya Kumar Thommandru · Pune, IN

Key dates

Filing date	May 26, 2010
Grant date	Dec 2, 2014
Priority date	—
Expiry date	May 26, 2030

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P9/10
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A novel controlled release pharmaceutical dosage form comprising a therapeutically effective amount of ranolazine or pharmaceutically acceptable salt(s), polymorph(s), solvate(s), hydrate(s), enantiomer(s) thereof, one or more lipid(s) as release controlling agent(s) and one or more pharmaceutically acceptable excipient(s).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.